Volume 40, Issue 6 pp. e65-e68
SHORT COMMUNICATION
Full Access

Cardiopulmonary and sedative effects of intravenous or epidural methadone in conscious dogs

B. H. B. Vieira

B. H. B. Vieira

Veterinary Science Graduate Program, University of Franca, Franca, SP, Brazil

Search for more papers by this author
L. T. Nishimura

L. T. Nishimura

Veterinary Science Graduate Program, University of Franca, Franca, SP, Brazil

Search for more papers by this author
L. L. Carvalho

L. L. Carvalho

Veterinary Science Graduate Program, University of Franca, Franca, SP, Brazil

Search for more papers by this author
A. Auckburally

A. Auckburally

Department of Small Animal Clinical Sciences, School of Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK

Search for more papers by this author
E. Mattos-Junior

Corresponding Author

E. Mattos-Junior

Veterinary Science Graduate Program, University of Franca, Franca, SP, Brazil

Correspondence

Ewaldo Mattos-Junior, Veterinary Science Graduate Program, University of Franca, Franca, SP, Brazil.

Email: [email protected]

Search for more papers by this author
First published: 15 May 2017
Citations: 5

Abstract

Cardiopulmonary and sedative effects of intravenous or epidural methadone were compared. Six beagles were randomly assigned to group MIV (methadone 0.5 mg/kg IV + NaCl 0.9% epidurally) or MEP (methadone 0.5 mg/kg epidurally + NaCl 0.9% IV). Cardiopulmonary, blood gas and sedation were assessed at time (T) 0, 15, 30, 60, 120, 240 and 480 min after drug administration. Compared to T0, heart rate decreased at T15–T120 in MIV (< .001) and T15–T240 in MEP (< .05); mean arterial pressure was reduced at T15–T60 in MEP (< .01); respiratory rate was higher at T15 and T30 in both groups (< .05); pH was lower at T15–T120 in MIV (< .01) and T15, T30 and T120 in MEP (< .05); PaCO2 was higher at T15–T60 in MIV (< .01) and T15, T30 and T120 in MEP (< .01); sedation scores were higher at T15 and T30 in MIV and T15–T60 in MEP (< .05). At T120 and T240, sedation score was higher in group MEP compared with group MIV (< .01) In conclusion, cardiopulmonary and sedative effects of identical methadone doses are similar when administered IV or epidurally to conscious healthy dogs.

Epidural (EP) administration of opioids (principally morphine) provides better antinociception, with minimal cardiorespiratory effects compared with other routes of administration (Pascoe, 2000). Furthermore, lower doses are required and the duration of antinociception is longer (Valverde, Conlon, Dyson, & Burger, 1992). Methadone, a synthetic opioid with additional antinociceptive properties, results in fewer adverse effects than morphine when administered EP to women undergoing obstetrical procedures (Beeby, MacIntosh, Bailey, & Welch, 1984). Nevertheless, due to its lipophilicity, there is little advantage of methadone administered epidurally as there is significant systemic uptake (Davis & Walsh, 2001). This study compared sedative and cardiopulmonary effects of methadone given IV or EP to healthy, conscious dogs, during 8 hr of assessment.

The Institutional Ethics Committee on Animal Care approved this research (protocol number 032/13). Six healthy 2-year-old beagle dogs (four male; two female) weighing 15.3 ± 2.2 kg were used. Animals were conditioned for 30 days prior to the study and fasted for 8 hr and water was restricted for 4 hr immediately before the study.

Dogs received one of two treatments in a randomized crossover design with a minimum interval of 7 days between treatments. Group MIV received 0.5 mg/kg methadone (Metadon, Critstália, Itapira, Brazil) IV and normal saline (Fisiológico, JP Indústria Farmacêutica S.A., Ribeirão Preto, Brazil) epidurally; group MEP received 0.5 mg/kg methadone epidurally and normal saline IV. Final volumes were adjusted to 0.4 ml/kg with normal saline and administration was performed simultaneously. Sedation scores, cardiopulmonary and blood gas measurements and body temperature, were recorded before administration (T0), and 15, 30, 60, 120, 240 and 480 min following administration (T15–T480).

An epidural catheter (Becton Dickinson, BD™ Catheter Epidural, São Paulo, SP, Brazil) was placed at the lumbosacral junction using a technique described by Valverde (2008). Dogs were anaesthetized using IV propofol (Propovan, Cristália, Brazil), and maintained with increments. Pulse rate, respiratory rate (fR) and haemoglobin oxygen saturation using pulse oximetry (SpO2) were monitored and animals allowed to recover completely.

Heart rate (HR) and cardiac rhythm were assessed using electrocardiography (TEB® ECGPC software v. 1.1, São Paulo, Brazil). A 22G × 1″ catheter was placed in a dorsal metatarsal artery and connected to a calibrated manometer (Bic Med, Itupeva, Brazil) to measure mean arterial blood pressure (MAP). The system was zeroed at the level of the right atrium. Rectal temperature (RT—Celsius degrees °C) was assessed using a clinical thermometer (Flexterm, Incoterm, Porto Alegre, Brazil). Respiratory rate was evaluated by observation. Arterial blood samples were analysed immediately (pH, partial pressure of carbon dioxide (PaCO2), partial pressure of oxygen (SaO2), arterial haemoglobin oxygen saturation, base excess (BE), bicarbonate ([HCO3]), sodium, potassium and chloride ion concentrations), using an automatic analyzer (Cobas b 121 Roche®, Basel, Switzerland). Three evaluators, blinded to the route of methadone administration, scored sedation according to a scale proposed by Kuusela et al. (2000) (Appendix 1). The final score was the mean of the three evaluators and used for statistical analysis.

Normality was assessed (Shapiro-Wilk's test) and data analysed using GraphPad PRISM v. 5 (GraphPad Software, Inc., La Jolla, CA, USA). Repeated measures two-way ANOVA and Bonferroni's post-test were used for comparison of cardiopulmonary variables, RT and blood gas measurements among time points and Student's t test for between treatment comparisons. Sedation scores were compared using Friedman's test and Dunn's post-test, if necessary. Significance was set at 5%.

Results are shown as mean ± standard deviation (SD), for parametric data and median (range) for nonparametric data.

Cardiopulmonary data are shown in Table 1. There were no significant differences between treatments (> .05). HR was decreased from T15–T120 in MIV (< .001) and T15–T120 (< .001) and T240 (< .05) in MEP, when compared to baseline. No changes in cardiac rhythm occurred. In group MEP, a significant decrease in MAP occurred at T15–T60 (< .01). Compared with baseline, fR was significantly increased at T15 and T30 in group MIV (< .01), and at T15 and T30 in group MEP (< .05). Compared with baseline, RT was significantly decreased in group MIV at T30–T120 (< .05) and in group MEP at T15 (< .05), T30 (< .01) and, T60–T240 (< .001).

Table 1. Heart rate (HR), respiratory rate (fR), mean arterial pressure (MAP) and rectal temperature (RT) in six conscious beagles prior (0) to and following injection of methadone (0.5 mg/kg) intravenously (MIV) or epidurally (MEP) at different time points of evaluation
Variable Treatment Time of evaluation (min)
0 15 30 60 120 240 480
HR (bpm) MIV 127 ± 12 91 ± 18 95 ± 10 94 ± 19 94 ± 17 112 ± 19 122 ± 16
MEP 127 ± 28 91 ± 19 90 ± 28 94 ± 26 93 ± 18 105 ± 28 108 ± 25
MAP (mmHg) MIV 110 ± 14 103 ± 16 102 ± 12 108 ± 13 112 ± 8 111 ± 11 111 ± 11
MEP 120 ± 8 103 ± 5 104 ± 8 104 ± 6 113 ± 5 118 ± 8 115 ± 13
fR (bpm) MIV 44 ± 8 133 ± 61 126 ± 57 76 ± 58 58 ± 19 32 ± 8 54 ± 44
MEP 58 ± 6 143 ± 70 118 ± 67 83 ± 43 43 ± 20 54 ± 35 56 ± 45
RT (°C) MIV 38.4 ± 0.2 38.1 ± 0.5 37.7 ± 0.7 37.6 ± 0.7 37.6 ± 0.6 38.3 ± 0.3 38.5 ± 0.4
MEP 38.7 ± 0.2 38.2 ± 0.3 38 ± 0.3 37.6 ± 0.5 37.4 ± 0.6 37.9 ± 0.6 38.3 ± 0.2
  • Values expressed by mean ± SD.
  • bpm: beats per min (HR) or breaths per min (fR).
  • Statistically different from baseline (0) within the same treatment—ANOVA and Bonferroni's post-test (* < .05; **< .01; ***< .001).

Compared with baseline, mean pH values were significantly decreased at T15–T60 (< .001) and T120 (< .01) in group MIV, and at T15, T30 and T120 in group MEP (< .05). PaCO2 was significantly increased at T15, T30 (< .01) and T60 (< .001) in group MIV, and at T15, T30 and T120 in group MEP (< .01), compared with baseline. There were no significant differences in PaO2 and SaO2. There were no other significant differences between treatments in arterial blood gas and electrolyte measurements at any time point (> .05) (Table 2).

Table 2. Arterial pH (pH), partial pressure of carbon dioxide in arterial blood (PaCO2), partial pressure of oxygen in arterial blood (PaO2), arterial haemoglobin oxygen saturation (SaO2), base excess (BE), bicarbonate ([HCO3]), sodium ([Na+]), potassium ([K+]) and chloride ([Cl]) concentrations in six conscious beagles prior (0) to and following injection of methadone (0.5 mg/kg) intravenously (MIV) or epidurally (MEP) at different time points of evaluation
Variable Treatment Time of evaluation (min)
0 15 30 60 120 240 480
pH MIV 7.42 ± 0.02 7.37 ± 0.02 7.36 ± 0.02 7.37 ± 0.02 7.39 ± 0.02 7.42 ± 0.02 7.43 ± 0.02
MEP 7.41 ± 0.02 7.37 ± 0.02 7.38 ± 0.01 7.38 ± 0.01 7.37 ± 0.02 7.42 ± 0.03 7.42 ± 0.02
PaCO2 (mmHg) MIV 30 ± 3 36 ± 2 36 ± 4 37 ± 3 32 ± 4 29 ± 3 29 ± 3
MEP 30 ± 1 35 ± 3 35 ± 1 34 ± 3 34 ± 3 32 ± 2 31 ± 4
PaO2 (mmHg) MIV 85 ± 5 80 ± 6 81 ± 6 84 ± 6 79 ± 4 80 ± 6 80 ± 5
MEP 85 ± 5 81 ± 4 84 ± 3 84 ± 4 83 ± 2 83 ± 5 80 ± 2
HCO3 (mmol/L) MIV 19 ± 2 20 ± 2 20 ± 2 21 ± 2 19 ± 2 18 ± 2 19 ± 2
MEP 19 ± 1 20 ± 1 20 ± 1 19 ± 1 20 ± 1 20 ± 1 20 ± 2
BE (mmol/L) MIV −4 ± 2 −4 ± 2 −5 ± 2 −4 ± 2 −5 ± 1 −5 ± 2 −5 ± 1
MEP −4 ± 1 −4 ± 1 −3 ± 4 −5 ± 1 −5 ± 0 −3 ± 2 −3 ± 2
SaO2 (%) MIV 96 ± 1 95 ± 1 95 ± 1 96 ± 1 95 ± 1 96 ± 1 96 ± 1
MEP 96 ± 0 95 ± 1 96 ± 0 96 ± 0 96 ± 0 96 ± 0 96 ± 0
Na+ (mmol/L) MIV 152.7 ± 4.4 152.3 ± 3.9 153.4 ± 4.6 154.5 ± 3.6 154.6 ± 3.7 153.8 ± 1.3 152.2 ± 4.8
MEP 151.4 ± 4 151.2 ± 2.6 152.3 ± 3.1 152.9 ± 3.3 152.5 ± 3.2 153.2 ± 2.5 151.3 ± 3.2
K+ (mmol/L) MIV 4 ± 0.2 3.8 ± 0.2 3.8 ± 0.2 3.9 ± 0.1 3.9 ± 0.3 3.9 ± 0.2 3.7 ± 0.4
MEP 3.8 ± 0.3 3.7 ± 0.2 3.5 ± 0.4 3.7 ± 0.4 3.8 ± 0.2 3.2 ± 0.4 3.5 ± 0.6
Cl (mmol/L) MIV 117.2 ± 4.8 114.8 ± 5 116.7 ± 6.4 116.4 ± 4.9 116.1 ± 3.2 116.6 ± 3.3 116.1 ± 7.2
MEP 116.3 ± 4.9 114 ± 2.3 115.8 ± 2.3 115.9 ± 3.2 115.6 ± 2.9 115.4 ± 3.8 114.1 ± 4.1
  • Values expressed by mean ± SD.
  • Statistically different from baseline (0) within the same treatment—ANOVA and Bonferroni's post-test (*< .05; **< .01; ***< .001).

Sedation scores were higher in comparison with baseline at T15 and T30 in group MIV, and at T15–T60 in group MEP (< .05). At T120 and T240, sedation score was higher in group MEP compared with group MIV (< .01) (Table 3). One animal in group MIV demonstrated clinical signs of CNS excitation (dysphoria) up to 60 min following drug administration. This behaviour was not evident prior to methadone administration.

Table 3. Sedation scores in six conscious dogs’ prior (0) to and following injection of methadone (0.5 mg/kg) intravenously (MIV) or epidurally (MEP) at different time points (min) of evaluation
Treatment 0 15 30 60 120 240 480
MIV 0 5 (0–8) 4 (0–8) 3 (0–5) 1 (0–2)A 1 (0–2)A 0 (0–1)
MEP 0 6 (5–7) 6 (5–7) 4 (4–6) 3 (2–4)B 2 (0–3)B 0 (0–2)
  • Data are given median (minimum–maximum).
  • a Friedman's and Dunn's post-test (*< .05).
  • Capital letters indicate differences (< .05) between treatments (A<B).

This study demonstrates that cardiopulmonary and sedative effects are similar when identical doses of methadone are administered IV or EP to healthy, conscious dogs.

Alterations in HR induced by methadone are usually attributed to direct action on vagal tone (Stanley, Liu, Webster, & Johansen, 1980). Additionally, a baroreceptor-mediated fall in HR has been described in response to vasoconstriction and increased systemic vascular resistance (Hellebrekers, Van Den Brom, & Mol, 1989; Maiante, Teixeira Neto, Beier, Corrente, & Pedroso, 2009). This increased blood pressure may be a consequence of CNS excitation (Maiante et al., 2009) or the secretion of arginine vasopressin (AVP) (Hellebrekers et al., 1989; Maiante et al., 2009). We did not observe an increase in MAP following methadone administration and cannot corroborate this peripheral effect on HR or on the secretion of AVP; this may be a reflection of the dose of methadone used in our study. In a study in isoflurane-anaesthetized dogs, a fall in HR occurred almost immediately following IV injection of methadone; such an effect was observed only after 10–50 min following epidural administration (Campagnol et al., 2012).

In our study, panting occurred for up to 30 min following administration of methadone in both groups. This systemic effect of methadone has been described in conscious dogs (Maiante et al., 2009). Panting observed following administration of μ agonist opioids, may be secondary to changes in the thermoregulatory centre and the animal attempting to cool itself down (Pascoe, 2000). The RT of dogs in both groups fell significantly over time (but was not clinically significant), in agreement with Maiante et al. (2009), which may be attributable to this effect on the thermoregulatory centre. However, sedation also induces reduced muscular function, which may lead to RT depression.

There were minimal changes in acid base status, blood gas values and electrolyte concentrations in our study. Oxygenation was unaffected despite a reduction in ventilation evidenced by an increase in PaCO2.. This increase in PaCO2 was similar between groups and clinically insignificant but was suggestive of systemic uptake of EP methadone. Arterial pH decreased following methadone administration in both groups but was attributed to increases in PaCO2 and was not clinically significant. Other studies have produced similar findings (Garofalo et al., 2012), although alternative speculative explanations have included the development of a mild metabolic acidosis as a result of reduced tissue perfusion secondary to elevations in AVP concentrations (Garofalo et al., 2012; Hellebrekers et al., 1989). As we did not identify significant changes in [HCO3] or BE, we cannot corroborate this theory.

Systemic absorption of drugs from the EP space is determined in part by lipophilicity (Valverde, 2008). The lipophilic nature of methadone may explain the similarity of sedation scores observed in this study between treatments. In light of the results presented in this study, it is difficult to recommend the administration of methadone epidurally, as sedation was similar and of longer duration following administration via this route.

A limitation of this study was that analgesic potency of the treatments was not assessed. Although identical doses of methadone were administered by both routes, it might be expected that analgesia in group MEP would be superior compared to group MIV. As the drug is administered close to the effect site a smaller dose of methadone may produce similar analgesic effects. Furthermore, as doses were identical, the sedative and cardiopulmonary effects are likely to be similar between groups due to systemic absorption of methadone administered epidurally. However, plasma concentrations were not measured and we cannot confirm that this is true. Further studies are warranted to assess the analgesic potency of lower doses of methadone administered by the EP route.

In conclusion, identical doses of methadone administered IV or EP lead to similar cardiopulmonary changes in healthy, conscious dogs with longer effects when administered epidurally.

APPENDIX 1

Sedative score

Feature Score
Posture

0 Normal; standing

1 Sternal recumbency

2 Alternating, sternal and lateral recumbency

3 Lateral recumbency

Palpebral reflex

0 Normal

1 Slightly reduced

2 Moderately reduced

3 Very slow or absent

Position of the eye

0 Centered

1 Slightly rotated

2 Rotated

Relaxation of the jaws and the tongue

0 Without relaxation

1 Slight relaxation of the jaw; tongue remains in the mouth

2 Moderate relaxation of the jaw; tongue easily protracted

3 Profound relaxation of the jaw; tongue remains outside the mouth spontaneously or when protracted

Response to sound (handclap)

0 Attention or scared of clap

1 Attention but not scared of clap

2 Moderate attention but not scared of clap

3 Without attention to environment and clap

General appearance

0 Interaction with environment and researchers

1 Moderate interaction with environment and researchers

2 Poor interaction with environment and researchers

3 Absent interaction with environment and researchers

  • Kuusela et al. (2000).

    The full text of this article hosted at iucr.org is unavailable due to technical difficulties.